In our study, Phosphatidylcholine (16:0_20:4), Sphingomyelin (d38:1), and Sterol ester (27:1/22:6) were found to reduce the risk of UC and IBD by lowering the levels of CCL4 in the body. Here, CCL4 is linked to inflammatory bowel disease.